Antigen-Pattern for an early diagnosis and Therapeutic approaches for Tumor diseases and COPD
This technology offer contains three patent applications of Saarland University that provide methods for the diagnosis of tumours in an early stage, especially in cases of lung and brain cancer and COPD (chronic obstructive pulmonary disease).
The technologies are using a single diagnostic marker or a panel of biomarkers to diagnose the diseases in an early stage which can imply an enormous improvement on the efficacy of subsequent therapies.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302
Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein
Media Contact
All latest news from the category: Technology Offerings
Newest articles
NTU and NUS spin-off cutting-edge quantum control technology
AQSolotl’s quantum controller is designed to be adaptable, scalable and cost-efficient. Quantum technology jointly developed at Nanyang Technological University, Singapore (NTU Singapore) and National University of Singapore (NUS) has now…
How Geothermal Energy Shapes Bavaria’s Green Future Through Sustainable Energy
The Bavarian State Ministry of Science and the Arts has extended its funding for the research association “Geothermal Alliance Bavaria,” with the University of Bayreuth (UBT) continuing as a member…
Spintronics memory innovation: A new perpendicular magnetized film
Long gone are the days where all our data could fit on a two-megabyte floppy disk. In today’s information-based society, the increasing volume of information being handled demands that we…